Showing results (2301-2310 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|March 2, 2026
QT Prolongation Risk of Antibody-Drug ConjugatesXu Steven Xu, Kinjal Sanghavi, Summer Feng, et al.Drug Safety|March 21, 2026
International Medicinal Product Information Documents: A Quantitative Content Analysis of Instructions for Preventing, Mitigating, and Monitoring Adverse Drug ReactionsDaniele Sartori, Michele Fusaroli, Jeffrey K Aronson, et al.Drug Safety|May 1, 2026
Educational Interventions Affecting Medication Error Reporting by Healthcare Professionals in Secondary and Tertiary Care: A Systematic Review and Narrative SynthesisManahil M Monshi, Zahraa Jalal, Jeff Aston, et al.Drug Safety|March 30, 2026
Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in US Medicare Adults Age 65 Years or OlderSusan Dos Reis, Yueh-Yi Chiang, Alejandro Amill-Rosario, et al.Drug Safety|March 30, 2026
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future ImprovementsDawn Cooper, Mohammed Toseef Ansari, Taylor Aurelius, et al.Drug Safety|March 18, 2026
Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist ElinzanetantJames H Lewis, Raúl J Andrade, Dominique Larrey, et al.Drug Safety|June 2, 2026
Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control StudyAnna-Belle Beau, Erika Cifuentes Castro, Justine Benevent, et al.Drug Safety|September 12, 2023
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational StudiesTsutomu Takeuchi, Kiyohiro Nishikawa, Fumika Yamada, et al.Drug Safety|July 27, 2017
Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in JapanKazuki Ozawa, Akiyo Hineno, Tomomi Kinoshita, et al.Drug Safety|February 22, 2015
Comparative safety and tolerability of anti-VEGF therapy in age-related macular degenerationYasha S Modi, Carley Tanchon, Justis P EhlersPageof 311